Table 1 Patients characteristics

AGE (range)

TUMOR SIZE

0–1

64

(98)

≧2

1

(2)

FIGO (2018)

I-IIA

23

(35)

IIB-IVA

34

(52)

IVB

8

(12)

–

31

(48)

+

34

(52)

No chemo

12

(18)

Small cell regimen (SCC)

35

(54)

CDDP(or CBDCA) + VP16

22

≧4course

11

≦3course

11

CDDP(or CBDCA) + CPT11

13

≧6course

10

≦5course

3

Non-small cell regimen

18

(28)

CDDP(or CBDCA) + 5FU

8

≧3course

4

≦2course

4

NED + 5FU

5

≧3course

3

≦2course

2

wCDDP

3

DOC or PTX + CBDCA

2

Surgery

12

(18)

Local first

25

(38)

Surgery+CCRT

10

w/SCC regimen

4

Surgery+Chemo

15

w/SCC regimen

15

NAC

7

(11)

CCRT+Surgery

4

w/SCC regimen

4

Chemo+Surgery

3

w/SCC regimen

2

CCRT(w/BT^a)

14(11)

(21(17))

w/SCC regimen

4(2)

Chemo

7

(11)

w/SCC regimen

6